全文获取类型
收费全文 | 6926篇 |
免费 | 360篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 150篇 |
妇产科学 | 186篇 |
基础医学 | 970篇 |
口腔科学 | 492篇 |
临床医学 | 432篇 |
内科学 | 1631篇 |
皮肤病学 | 96篇 |
神经病学 | 697篇 |
特种医学 | 141篇 |
外科学 | 1022篇 |
综合类 | 42篇 |
一般理论 | 3篇 |
预防医学 | 449篇 |
眼科学 | 185篇 |
药学 | 339篇 |
中国医学 | 38篇 |
肿瘤学 | 378篇 |
出版年
2023年 | 59篇 |
2022年 | 144篇 |
2021年 | 311篇 |
2020年 | 168篇 |
2019年 | 236篇 |
2018年 | 254篇 |
2017年 | 141篇 |
2016年 | 161篇 |
2015年 | 243篇 |
2014年 | 325篇 |
2013年 | 407篇 |
2012年 | 552篇 |
2011年 | 650篇 |
2010年 | 317篇 |
2009年 | 289篇 |
2008年 | 492篇 |
2007年 | 439篇 |
2006年 | 469篇 |
2005年 | 393篇 |
2004年 | 339篇 |
2003年 | 281篇 |
2002年 | 243篇 |
2001年 | 34篇 |
2000年 | 26篇 |
1999年 | 24篇 |
1998年 | 39篇 |
1997年 | 26篇 |
1996年 | 28篇 |
1995年 | 19篇 |
1994年 | 16篇 |
1993年 | 14篇 |
1992年 | 10篇 |
1991年 | 7篇 |
1990年 | 8篇 |
1989年 | 6篇 |
1988年 | 8篇 |
1987年 | 9篇 |
1985年 | 7篇 |
1984年 | 8篇 |
1983年 | 9篇 |
1982年 | 5篇 |
1980年 | 7篇 |
1979年 | 7篇 |
1978年 | 4篇 |
1975年 | 6篇 |
1974年 | 6篇 |
1973年 | 8篇 |
1972年 | 9篇 |
1971年 | 8篇 |
1970年 | 4篇 |
排序方式: 共有7317条查询结果,搜索用时 15 毫秒
51.
Fernando Korn Malerbi Gustavo Barreto Melo 《Bulletin of the World Health Organization》2022,100(10):643
ProblemThere is currently no national strategy or standardized approach to diabetic retinopathy screening in the Brazilian public health system, and multiple socioeconomic barriers prevent access to eye examination in Brazil’s poorest regions.ApproachFrom September 2021 to March 2022 we carried out a pilot project with an artificial intelligence system for diabetic retinopathy screening, embedded in a portable retinal camera. Patients with a diagnosis of diabetes according to the municipality registry were invited to attend nearby clinics for screening on designated days. Trained health-care technicians acquired images which were automatically evaluated by the system, with instant remote evaluation by retinal specialists in selected cases.Local settingOur study was based in Sergipe State, located at a region with high illiteracy rates and no local availability of specialized retina care. The average number of laser treatments performed annually in the last 5 years is 126, for a total State population of 2.3 million.Relevant changesEven though screening was performed free of charge in a convenient location for patients, from a total 2052 eligible individuals, only 1083 attended for screening.Lessons learntEfforts to raise awareness on the condition screened and to provide health education for patients and local health-care personnel are fundamental for increased attendance. Tailoring screening systems to the local setting, such as determining the trade-off between sensitivity and specificity, is challenging in regions with no current benchmarks. Standards for retinopathy screening based on the strategies adopted by high-income countries may not be realistic in low- and middle-income countries. 相似文献
52.
Adrian Lewis Alejandro Josiowicz Stella Maris Hirmas Riade Monica Tous Gustavo Palacios Daniel M. Cisterna 《Emerging infectious diseases》2022,28(10):2123
We report detection of cases of monkeypox virus infection in Argentina in the context of a marked increase in confounding cases of atypical hand-foot-and-mouth syndrome caused by enterovirus coxsackie A6. We recommend performing an accurate differential virological diagnosis for exanthematous disease in suspected monkeypox cases. 相似文献
53.
Jimmy MartinDelgado Aurora Mula Mercedes Guilabert Carlos Solís Lorena Gmez Gustavo Ramirez Amat Jos Joaquin Mira EPD Research Group 《Health expectations》2022,25(5):2134
IntroductionThe global prevalence of diabetes in 2019 in adults was estimated to be 9.3%. This study developed in Ecuador, for the first time, instruments to assess patient‐reported outcomes and experiences.MethodsThe Experiences of the Person with Diabetes (EPD) Questionnaire is a diabetes‐specific instrument. A mixed‐methods study was conducted. First, a qualitative item development phase that included four focus groups and six semi‐structured interviews with patients was conducted in different rural and urban areas of Ecuador to obtain information on culture, beliefs, demographics, diet and social perspectives. A second quantitative phase for psychometric validation was carried out in primary care settings of rural and urban areas of Ecuador.ResultsForty‐two and four hundred and eighty‐nine participants were included in each phase, respectively. The item development phase resulted in a questionnaire of 44 items (23 for perceived outcomes and 21 for experiences). In the validation study, most participants were women (58%) and from urban areas (57%). Exploratory factor analysis revealed three dimensions for each instrument. Outcomes instrument dimensions were symptoms and burnout, worries and fears and social limitations. Experiences instrument dimensions were information, patient‐centred care and care delivery. Cronbach''s α values of the total score and dimensions were high, ranging between .81 and .93 in both instruments. Confirmatory factor analysis showed an acceptable fit of the data.ConclusionThe EPD Questionnaire is probably the first instrument developed to assess patient‐reported experiences and perceived outcomes in a middle‐income country that included patients to capture all dimensions relevant for the intended population. Its psychometric properties are robust and could provide valuable information for clinicians and policymakers in the region.Patient or Public ContributionThe development of these instruments has taken into consideration patients and the public since their conception. A qualitative approach gathered relevant information related to the cultural, social and economic burden of different populations in Ecuador. Before validation, a pilot test was carried out with users of the National Health Services to obtain their perspectives and insights of the developed instrument. Finally, during the data analysis, we have given special consideration to social variables such as rural and urban populations. 相似文献
54.
Edinson Dante Meregildo-Rodriguez Luis Gianmarco Robles-Arce Eleodoro Vladimir Chunga-Chvez Martha Genara Asmat-Rubio Petterson Zavaleta-Alaya Gustavo Adolfo Vsquez-Tirado 《Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive》2022,30(4):501
55.
Mnica Volino-Souza Gustavo Vieira de Oliveira Carlos Adam Conte-Junior Arturo Figueroa Thiago Silveira Alvares 《Nutrients》2022,14(14)
The amino acid L-arginine is crucial for nitric oxide (NO) synthesis, an important molecule regulating vascular tone. Considering that vascular dysfunction precedes cardiovascular disease, supplementation with precursors of NO synthesis (e.g., L-arginine) is warranted. However, supplementation of L-citrulline is recommended instead of L-arginine since most L-arginine is catabolized during its course to the endothelium. Given that L-citrulline, found mainly in watermelon, can be converted to L-arginine, watermelon supplementation seems to be effective in increasing plasma L-arginine and improving vascular function. Nonetheless, there are divergent findings when investigating the effect of watermelon supplementation on vascular function, which may be explained by the L-citrulline dose in watermelon products. In some instances, offering a sufficient amount of L-citrulline can be impaired by the greater volume (>700 mL) of watermelon needed to reach a proper dose of L-citrulline. Thus, food technology can be applied to reduce the watermelon volume and make supplementation more convenient. Therefore, this narrative review aims to discuss the current evidence showing the effects of watermelon ingestion on vascular health parameters, exploring the critical relevance of food technology for acceptable L-citrulline content in these products. Watermelon-derived L-citrulline appears as a supplementation that can improve vascular function, including arterial stiffness and blood pressure. Applying food technologies to concentrate bioactive compounds in a reduced volume is warranted so that its ingestion can be more convenient, improving the adherence of those who want to ingest watermelon products daily. 相似文献
56.
57.
Andreu GL Maurmann N Reolon GK de Farias CB Delgado R Roesler R 《Arzneimittel-Forschung》2011,61(7):382-385
Mangiferin (1,3,6,7-tetrahydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] -xanthen-9-one, CAS 4773-96-0), a naturally occurring glucosylxanthone, is widely distributed in higher plants and a constituent of folk medicine. In the present study the effect of systemic administration of mangiferin on behavioural outcomes of neurological function in normal rats was investigated. A single intraperitoneal injection of mangiferin (10, 50 and 100 mg/kg body weight) immediately post-training produced an impairment of long-term memory for aversive training and a reduced freezing in a dose independent manner, when given immediately post-training. The administration of mangiferin 6 h post-training did not affect fear memory. The results indicate that mangiferin might induce deficits of emotionally motivated memory. 相似文献
58.
Daiane Cristina Sass Alessandra Vincenzi Jager Fernando Gustavo Tonin Roice Eliana Rosim Mauricio Gomes Constantino 《Toxin reviews》2015,34(1):53-59
This work reports the chemical synthesis of aflatoxin B1 (AFB1)-lysine based on procedures available in the literature, but using lysine without a protection group in the α-amine group. AFB1-exo-8,9-epoxide was obtained by epoxidation of AFB1 with chloroperoxybenzoic acid in dichloromethane and phosphate buffer. Purification and identification of the AFB1-lysine were conducted by liquid chromatography (LC), and its structure was confirmed by LC with mass spectrometer and diode-array detection. The preparation of AFB1-lysine using lysine without a protection group in the α-amine group was completed in 24?h, being a practical modification of available methods that can be reproduced in analytical laboratories. 相似文献
59.
AIM: To assess the efficacy and safety of patterned laser trabeculoplasty (PLT) as an adjunctive treatment in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients who were under antiglaucoma medical treatment.
METHODS: This study was a retrospective review of primary or secondary OAG patients and OHT patients with medically uncontrolled (≥18 mm Hg) intraocular pressure (IOP) who underwent 360º PLT from June 2016 to August 2016. Follow-up visits at week 1, and 1, 3 and 6mo were performed. IOP, best corrected visual acuity (BCVA), complications and eye drop glaucoma medication were recorded at each follow-up visit. Success was defined as IOP reduction ≥20% from baseline.
RESULTS: Forty one eyes of 25 patients were included in this study. Pre-treatment mean IOP was 20.2±1.6 mm Hg. After PLT, IOP was 19.3±5.2, 16.1±2.7, 17.1±3.7 and 16.3±3.5 mm Hg, at 1wk, 1, 3 and 6mo, respectively. IOP reduction from baseline was statistically significant from the first month, remaining stable at 6mo (P<0.001). PLT success at 6mo of follow-up was 48.7%. The number of glaucoma medication per eye (P=0.10) and the mean BCVA both remained constant (P=0.37). Complications included transient IOP spikes in 4 eyes (9.7%) and peripheral anterior synechiae in 7 eyes (17.1%).
CONCLUSION: PLT is an effective and safe method for the management of patients with OHT or OAG as an adjunctive therapy. Additional larger studies should be designed to verify the long-term stability of IOP reduction with this laser technology. 相似文献
60.
Bruna Andersen Pereira de Jesus Anderson Albino Gomes Alex E. Clark Tayse Andrade Rodrigues Melissa Ledgerwood-Lee Westley Van Zant Howard Brickner Meiqiao Wang David L. Blum Maria B. Cassera Aaron F. Carlin Eliah S. Aronoff-Spencer Gustavo Felippe da Silva Maria de Lourdes Borba Magalhes Partha Ray 《Viruses》2022,14(12)
The recent development and mass administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines allowed for disease control, reducing hospitalizations and mortality. Most of these vaccines target the SARS-CoV-2 Spike (S) protein antigens, culminating with the production of neutralizing antibodies (NAbs) that disrupt the attachment of the virus to ACE2 receptors on the host cells. However, several studies demonstrated that the NAbs typically rise within a few weeks after vaccination but quickly reduce months later. Thus, multiple booster administration is recommended, leading to vaccination hesitancy in many populations. Detecting serum anti-SARS-CoV-2 NAbs can instruct patients and healthcare providers on correct booster strategies. Several in vitro diagnostics kits are available; however, their high cost impairs the mass NAbs diagnostic testing. Recently, we engineered an ACE2 mimetic that interacts with the Receptor Binding Domain (RBD) of the SARS-2 S protein. Here we present the use of this engineered mini-protein (p-deface2 mut) to develop a detection assay to measure NAbs in patient sera using a competitive ELISA assay. Serum samples from twenty-one patients were tested. Nine samples (42.8%) tested positive, and twelve (57.1%) tested negative for neutralizing sera. The data correlated with the result from the standard commercial assay that uses human ACE2 protein. This confirmed that p-deface2 mut could replace human ACE2 in ELISA assays. Using bacterially expressed p-deface2 mut protein is cost-effective and may allow mass SARS-CoV-2 NAbs detection, especially in low-income countries where economical diagnostic testing is crucial. Such information will help providers decide when a booster is required, reducing risks of reinfection and preventing the administration before it is medically necessary. 相似文献